CNH Partners »

Revance Therapeutics shares owned by CNH Partners

Quarter-by-quarter ownership of Revance Therapeutics shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by CNH Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 15M 0.86

More positions owned by CNH Partners

Endeavor Group Hldgs Cl A Com (EDR)
Southwestern Energy Company
American Airls Put Option (AAL)
Stride Note 1.125% 9/0 (Principal)
American Airlines Group Note 6.500% 7/0 (Principal)
Microstrategy Cl A New Put Option (MSTR)
Championx Corp (CHX)
Sea Sponsord Ads Put Option (SE)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Dropbox Note 3/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Axonics Modulation Technolog (AXNX)
Interdigital Note 3.500% 6/0 (Principal)
Transocean Deb 4.625% 9/3 (Principal)

View all positions for CNH Partners

Top funds holding Revance Therapeutics

Graham Capital Management
Glazer Capital
Nuveen Asset Management
D. E. Shaw & Co
CNH Partners
Morgan Stanley
Jpmorgan Chase & Co
Citigroup
Amundi
Sonora Investment Management Group
BlackRock
BlackRock
Aviva
Point72 Asset Management
CSS

View all funds holding Revance Therapeutics